Skip Navigation

Free To Choose Medicine

October 1, 2013
By Gregory Conko and Bartley J. Madden

The U.S. Food and Drug Administration approved 39 new medicines in 2012, the largest number in 16 years. Some, including the agency itself, are proclaiming a new era of cooperation and productivity for the pharmaceutical industry and the FDA.

stethoscope and insurance docs

The U.S. Food and Drug Administration approved 39 new medicines in 2012, the largest number in 16 years. Some, including the agency itself, are proclaiming a new era of cooperation and productivity for the pharmaceutical industry and the FDA. But a closer look at what’s happening in the industry reveals deep problems. Development costs are rising, research pipelines are drying up, and as medical science targets more complex diseases such as cancer and Alzheimer’s, it has become increasingly more difficult to translate basic scientific discoveries into marketable products that work well in the clinic.

Article Tags
Health Care